VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $129 | -100.0% | 29,778 | -70.7% | 0.00% | -100.0% |
Q1 2022 | $1,151,000 | -72.3% | 101,763 | -61.5% | 0.00% | -80.0% |
Q4 2021 | $4,150,000 | -29.3% | 264,529 | -22.7% | 0.01% | -28.6% |
Q3 2021 | $5,866,000 | -35.3% | 342,243 | -18.8% | 0.01% | -36.4% |
Q2 2021 | $9,065,000 | +837.4% | 421,422 | +701.8% | 0.01% | +450.0% |
Q1 2019 | $967,000 | -20.0% | 52,559 | -39.2% | 0.00% | -50.0% |
Q1 2017 | $1,209,000 | – | 86,389 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |